SGHERZA, N. et al. 2021. Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma. Acta Biomedica Atenei Parmensis. 92, 2 (May 2021), e2021205. DOI:https://doi.org/10.23750/abm.v92i2.11395.